reference/15634168

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15634168

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2046-1402
pageRange	614-
publicationName	F1000Research
startingPage	614
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f6ce0d937f72a48c0cb4312b99819d99 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c072ac7eca75bc06461d9b2c1b14f90d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3f96713b26f6ad651f5b9da79bf4d1de
bibliographicCitation	Iwan K, Patel N, Heslegrave A, Borisova M, Lee L, Bower R, Mole SE, Mills PB, Zetterberg H, Mills K, Gissen P, Heywood WE. Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment. F1000Res. 2022 Jan 05;10():614. doi: 10.12688/f1000research.54556.2.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0763-8288 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe44f3eb653ea8089a7193cfa6e36bcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2106-8760 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a986e590e512a87d8174c8d1ac74a99e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c731286f95700e03b5c7f30ed6f0a34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe68b4cc883d1b99049708dd38d63a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb0eb99cc38140653cb44d8df686ee8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5223-0620 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7290-6405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8222680ef3e9958a962d8f88bdaef860 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3a85066eb22e7e9b125ac8c3e0a6d3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76cc3e88b31bcdd8202a81cc66dadc40
date	2021-07-20^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8777495 https://doi.org/10.12688/f1000research.54556.2 https://pubmed.ncbi.nlm.nih.gov/35106137 https://doi.org/10.12688/f1000research.54556.1
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40716 https://portal.issn.org/resource/ISSN/2046-1402
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment
discusses	http://id.nlm.nih.gov/mesh/M000748625 http://id.nlm.nih.gov/mesh/M0023752
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009472Q000188 http://id.nlm.nih.gov/mesh/D056947 http://id.nlm.nih.gov/mesh/D009472Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000091346 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015415 http://id.nlm.nih.gov/mesh/D007382
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42fc2c84597c9ec39f714142cab5e44d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c32599af9586780a12aaf1840962a216 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_289410c864fa16ac532a8cb251024c08 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9643 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8657 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7224

Showing number of triples: 1 to 51 of 51.